Predict your next investment

Venture Capital
mlscf.com

See what CB Insights has to offer

Investments

32

Portfolio Exits

6

Funds

1

About Malaysian Life Sciences Capital Fund

The Malaysian Life Sciences Capital Fund (MLSCF) specializes in early stage investments in the areas of agriculture, industrial and healthcare biotechnology. Co-managed by Malaysian Technology Development Corporation Sdn Bhd (MTDC) and Burrill & Company, the fund was founded in late 2006 and currently has USD150 million in committed capital. MLSCF is organized to invest in Leading, Privately Held Life Science companies with Malaysia centricity and deliver on the twin objectives of superior financial results and advancing the life science eco-system in and for the country of Malaysia.

Malaysian Life Sciences Capital Fund Headquarter Location

27 Jalan Sultan Ismail Level 36

Malaysia

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Malaysian Life Sciences Capital Fund

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Malaysian Life Sciences Capital Fund in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Malaysian Life Sciences Capital Fund Investments

32 Investments

Malaysian Life Sciences Capital Fund has made 32 investments. Their latest investment was in Greenlight Biosciences as part of their PIPE on February 2, 2022.

CBI Logo

Malaysian Life Sciences Capital Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/3/2022

PIPE

Greenlight Biosciences

$105M

No

1

6/16/2020

Series D - IV

Greenlight Biosciences

$102M

No

4

4/4/2019

Series C - IV

Inscripta

$20M

No

5

12/19/2018

Series C - III

Subscribe to see more

$99M

Subscribe to see more

10

2/28/2018

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/3/2022

6/16/2020

4/4/2019

12/19/2018

2/28/2018

Round

PIPE

Series D - IV

Series C - IV

Series C - III

Series C

Company

Greenlight Biosciences

Greenlight Biosciences

Inscripta

Subscribe to see more

Subscribe to see more

Amount

$105M

$102M

$20M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

5

10

10

Malaysian Life Sciences Capital Fund Portfolio Exits

6 Portfolio Exits

Malaysian Life Sciences Capital Fund has 6 portfolio exits. Their latest portfolio exit was LanzaTech on March 08, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/8/2022

Acq - Pending

$99M

2

2/3/2022

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

11/14/2016

Asset Sale

Subscribe to see more

$99M

Subscribe to see more

10

2/19/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/14/2014

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/8/2022

2/3/2022

11/14/2016

2/19/2016

4/14/2014

Exit

Acq - Pending

Reverse Merger

Asset Sale

Acquired

Reverse Merger

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Malaysian Life Sciences Capital Fund Fund History

1 Fund History

Malaysian Life Sciences Capital Fund has 1 fund, including MLS Capital Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/7/2015

MLS Capital Fund II

$150M

2

Closing Date

1/7/2015

Fund

MLS Capital Fund II

Fund Type

Status

Amount

$150M

Sources

2

Malaysian Life Sciences Capital Fund Team

1 Team Member

Malaysian Life Sciences Capital Fund has 1 team member, including current Chief Executive Officer, Ganesh Kishore.

Name

Work History

Title

Status

Ganesh Kishore

Chief Executive Officer

Current

Name

Ganesh Kishore

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.